Skip to content 
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified. more
| Time Frame | WDNA | S&P500 |
|---|---|---|
| 1-Week Return | 6.25% | -1.8% |
| 1-Month Return | 13.66% | -2.36% |
| 3-Month Return | 17.87% | 13.25% |
| 6-Month Return | 17.56% | 6.13% |
| 1-Year Return | 50.27% | 19.43% |
| 3-Year Return | 18.18% | 69.3% |
| 5-Year Return | -24.46% | 70.86% |
| 10-Year Return | -19.06% | 268.07% |
| Stock name | Ticker | Weight |
|---|---|---|
 Eli Lilly & Co | LLY | 3.98% |
 Twist Bioscience Corp | TWST | 3.56% |
 Moderna Inc | MRNA | 3.44% |
 Johnson & Johnson | JNJ | 3.14% |
 United Therapeutics Corp | UTHR | 3.03% |
 Immunome Inc | IMNM | 2.73% |
 Darling Ingredients Inc | DAR | 2.59% |
 Stoke Therapeutics Inc | STOK | 2.33% |
 Corteva Inc | CTVA | 2.28% |
 Beam Therapeutics Inc | BEAM | 2.09% |
 Tempus Ai Inc | TEM | 2.08% |
 ASTRAZENECA PLC | AZN | 2.07% |
 Isis Pharmaceuticals Inc | ISIS | 2.06% |
 Bunge Global Sa | 2318605D | 2.02% |
 Natera Inc | NTRA | 1.96% |
 Krystal Biotech Inc | KRYS | 1.94% |
 Crispr Therapeutics Ag | CRSP | 1.9% |
 Gilead Sciences Inc | GILD | 1.84% |
 Structure Therapeutics Inc | GPCR | 1.83% |
 Roivant Sciences Ltd | ROIV | 1.68% |
 Arrowhead Pharmaceuticals Inc | ARWR | 1.68% |
 Pfizer Inc | PFE | 1.67% |
 Amgen Inc | AMGN | 1.66% |
 Thermo Fisher Scientific Inc | TMO | 1.58% |
 Revolution Medicines Inc | RVMD | 1.56% |
 Novozymes A/S | NZYM.B.CO | 1.49% |
 Novartis AG | NOVN.SW | 1.47% |
 Bayer AG | BAYN.DE | 1.44% |
 Agios Pharmaceuticals Inc | AGIO | 1.41% |
 Vertex Pharmaceuticals Inc | VRTX | 1.41% |
 Catalyst Pharmaceuticals Inc | CPRX | 1.24% |
 10X Genomics Inc-Class A | TXG | 1.18% |
 Exelixis Inc | EXEL | 1.14% |
 Veracyte Inc | VCYT | 1.13% |
 Verbio AG | VBK.DE | 1.1% |
 Cullinan Therapeutics Inc | CGEM | 1.07% |
 Protagonist Therapeutics Inc | PTGX | 1.03% |
 Cg Oncology Inc | CGON | 1.03% |
 Biontech Se-ADR | BNTX | 1.01% |
 Allogene Therapeutics Inc | ALLO | 0.98% |
 Celldex Therapeutics Inc | CLDX | 0.98% |
 Editas Medicine Inc | EDIT | 0.98% |
 Biohaven Ltd | BHVN | 0.97% |
 Argenx Se - Adr | ARGX | 0.96% |
 Dyne Therapeutics Inc | DYN | 0.96% |
 ABSCI Corp | ABSI | 0.95% |
 Viking Therapeutics Inc | VKTX | 0.88% |
 Uniqure NV | QURE | 0.86% |
 Biogen Idec Inc | BIIB | 0.85% |
 FMC Corp | FMC | 0.8% |
 Iovance Biotherapeutics Inc | IOVA | 0.76% |
 Danaher Corp | DHR | 0.75% |
 Arcturus Therapeutics Hlgs | ARCT | 0.74% |
 Insmed Inc | INSM | 0.73% |
 Green Plains Inc | GPRE | 0.73% |
 Merck & Co Inc/NJ | MRK | 0.72% |
 Regeneron Pharmaceuticals Inc | REGN | 0.71% |
 Sana Biotechnology Inc | SANA | 0.7% |
 Halozyme Therapeutics Inc | HALO | 0.67% |
 Syensqo Sa | SYENS.BR | 0.64% |
 Repligen Corp | RGEN | 0.64% |
 Regenxbio Inc | RGNX | 0.56% |
 Ultragenyx Pharmaceutical Inc | RARE | 0.54% |
 Nufarm Ltd/Australia | NUF.AX | 0.53% |
 Bridgebio Pharma Inc | BBIO | 0.52% |
 Illumina Inc | ILMN | 0.51% |
 Intellia Therapeutics Inc | NTLA | 0.48% |
 Genmab A/S -Sp ADR | GMAB | 0.48% |
 BioMarin Pharmaceutical Inc | BMRN | 0.47% |
 Oxford Nanopore Technologies | ONT.L | 0.47% |
 Genus Plc | GNS.L | 0.44% |
 Zoetis Inc | ZTS | 0.44% |
 Geron Corp | GERN | 0.42% |
 Tyson Foods Inc | TSN | 0.4% |
 Techne Corp | TECH | 0.36% |
 Rocket Pharmaceuticals Inc | RCKT | 0.34% |
 Sarepta Therapeutics Inc | SRPT | 0.34% |
 Alnylam Pharmaceuticals Inc | ALNY | 0.33% |
 QIAGEN N.V. | QIAGEN.N.V. | 0.25% |
 Pacific Biosciences Of Calif | PACB | 0.22% |
 US DOLLAR | US.DOLLAR | 0.08% |
 DREYFUS TRSY OBLIG CASH MGMT CL INS | DREYFUS.TRSY.OBLIG.CASH.MGMT.CL.INS | 0.04% |
 EURO | EURO | 0% |
 AUSTRALIAN DOLLAR | AUSTRALIAN.DOLLAR | 0% |
 SWISS FRANC | SWISS.FRANC | 0% |
 GREAT BRITISH POUND | GREAT.BRITISH.POUND | 0% |
 DANISH KRONE | DANISH.KRONE | 0% |
| Sector | Weight |
|---|---|
|
Health care | 88.35% |
|
Materials | 6.97% |
|
Consumer staples | 4.68% |
WisdomTree BioRevolution Fund (WDNA) share price today is $20.2679.
Yes, Indians can buy shares of WisdomTree BioRevolution Fund (WDNA) on Vested. To buy WDNA from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of WisdomTree BioRevolution Fund (WDNA) on Vested. You can start investing in WisdomTree BioRevolution Fund (WDNA) with a minimum investment of $1.
The 52-week high price of WisdomTree BioRevolution Fund (WDNA) is $19.85. The 52-week low price of WisdomTree BioRevolution Fund (WDNA) is $12.73.
The stock symbol (or ticker) of WisdomTree BioRevolution Fund is WDNA.
Yes, you can setup SIP in WisdomTree BioRevolution Fund shares. Follow the below steps to create the SIP:
Here is the historical performance of WDNA on the Vested app.
The expense ratio of WisdomTree BioRevolution Fund (WDNA) is 0.45%.
Link copied 
